Guam

Guam

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
5.03 (4.31 - 5.86) 2019 Modelled IHME
5.12 (4.38 - 5.93) 2018 Modelled IHME
5.21 (4.35 - 6.12) 2017 Modelled IHME
5.36 (4.57 - 6.28) 2016 Modelled IHME
5.47 (4.63 - 6.38) 2015 Modelled IHME
5.44 (4.62 - 6.30) 2014 Modelled IHME
5.39 (4.58 - 6.22) 2013 Modelled IHME
5.33 (4.53 - 6.14) 2012 Modelled IHME
5.27 (4.46 - 6.06) 2011 Modelled IHME
5.25 (4.41 - 6.06) 2010 Modelled IHME
5.27 (4.46 - 6.05) 2009 Modelled IHME
5.32 (4.51 - 6.13) 2008 Modelled IHME
5.37 (4.57 - 6.19) 2007 Modelled IHME
5.41 (4.58 - 6.25) 2006 Modelled IHME
5.43 (4.59 - 6.33) 2005 Modelled IHME
5.41 (4.58 - 6.26) 2004 Modelled IHME
5.34 (4.49 - 6.24) 2003 Modelled IHME
5.27 (4.38 - 6.20) 2002 Modelled IHME
5.21 (4.25 - 6.17) 2001 Modelled IHME
5.18 (4.21 - 6.15) 2000 Modelled IHME
5.23 (4.28 - 6.17) 1999 Modelled IHME
5.34 (4.44 - 6.35) 1998 Modelled IHME
5.48 (4.60 - 6.56) 1997 Modelled IHME
5.59 (4.75 - 6.74) 1996 Modelled IHME
5.64 (4.78 - 6.84) 1995 Modelled IHME
5.64 (4.79 - 6.82) 1994 Modelled IHME
5.63 (4.77 - 6.80) 1993 Modelled IHME
5.6 (4.71 - 6.78) 1992 Modelled IHME
5.56 (4.62 - 6.76) 1991 Modelled IHME
5.49 (4.46 - 6.68) 1990 Modelled IHME
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
2.08 (1.41 - 2.84) 2019 Modelled IHME
2.1 (1.43 - 2.89) 2018 Modelled IHME
2.12 (1.44 - 2.97) 2017 Modelled IHME
2.2 (1.50 - 2.97) 2016 Modelled IHME
2.26 (1.54 - 3.02) 2015 Modelled IHME
2.25 (1.53 - 2.98) 2014 Modelled IHME
2.2 (1.50 - 2.91) 2013 Modelled IHME
2.14 (1.47 - 2.83) 2012 Modelled IHME
2.1 (1.44 - 2.78) 2011 Modelled IHME
2.08 (1.43 - 2.78) 2010 Modelled IHME
2.1 (1.44 - 2.79) 2009 Modelled IHME
2.14 (1.45 - 2.85) 2008 Modelled IHME
2.2 (1.46 - 2.94) 2007 Modelled IHME
2.24 (1.47 - 3.01) 2006 Modelled IHME
2.26 (1.45 - 3.04) 2005 Modelled IHME
2.26 (1.47 - 3.01) 2004 Modelled IHME
2.25 (1.47 - 3.01) 2003 Modelled IHME
2.24 (1.45 - 2.99) 2002 Modelled IHME
2.23 (1.44 - 2.99) 2001 Modelled IHME
2.23 (1.42 - 3) 2000 Modelled IHME
2.24 (1.45 - 3) 1999 Modelled IHME
2.28 (1.49 - 3.09) 1998 Modelled IHME
2.33 (1.55 - 3.20) 1997 Modelled IHME
2.37 (1.60 - 3.30) 1996 Modelled IHME
2.39 (1.62 - 3.38) 1995 Modelled IHME
2.39 (1.62 - 3.37) 1994 Modelled IHME
2.4 (1.62 - 3.37) 1993 Modelled IHME
2.4 (1.62 - 3.35) 1992 Modelled IHME
2.39 (1.61 - 3.29) 1991 Modelled IHME
2.38 (1.59 - 3.31) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
58 (49 - 67) 2019 Modelled IHME
58 (49 - 67) 2018 Modelled IHME
59 (49 - 67) 2017 Modelled IHME
59 (50 - 68) 2016 Modelled IHME
59 (50 - 68) 2015 Modelled IHME
59 (51 - 68) 2014 Modelled IHME
59 (51 - 67) 2013 Modelled IHME
59 (51 - 67) 2012 Modelled IHME
59 (51 - 68) 2011 Modelled IHME
59 (51 - 68) 2010 Modelled IHME
59 (51 - 67) 2009 Modelled IHME
59 (51 - 67) 2008 Modelled IHME
59 (51 - 67) 2007 Modelled IHME
59 (51 - 68) 2006 Modelled IHME
59 (51 - 68) 2005 Modelled IHME
58 (50 - 67) 2004 Modelled IHME
58 (50 - 66) 2003 Modelled IHME
58 (50 - 67) 2002 Modelled IHME
58 (50 - 67) 2001 Modelled IHME
58 (50 - 67) 2000 Modelled IHME
58 (49 - 66) 1999 Modelled IHME
58 (49 - 66) 1998 Modelled IHME
57 (49 - 66) 1997 Modelled IHME
57 (48 - 65) 1996 Modelled IHME
57 (48 - 66) 1995 Modelled IHME
57 (48 - 66) 1994 Modelled IHME
57 (48 - 66) 1993 Modelled IHME
57 (48 - 66) 1992 Modelled IHME
57 (48 - 66) 1991 Modelled IHME
57 (48 - 67) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
0 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.43 (0.34 - 0.52) 2019 Modelled IHME
0.42 (0.34 - 0.52) 2018 Modelled IHME
0.42 (0.34 - 0.52) 2017 Modelled IHME
0.42 (0.34 - 0.51) 2016 Modelled IHME
0.42 (0.34 - 0.51) 2015 Modelled IHME
0.42 (0.34 - 0.51) 2014 Modelled IHME
0.42 (0.34 - 0.51) 2013 Modelled IHME
0.42 (0.34 - 0.51) 2012 Modelled IHME
0.42 (0.34 - 0.51) 2011 Modelled IHME
0.42 (0.34 - 0.51) 2010 Modelled IHME
0.42 (0.34 - 0.51) 2009 Modelled IHME
0.42 (0.34 - 0.51) 2008 Modelled IHME
0.42 (0.34 - 0.51) 2007 Modelled IHME
0.42 (0.34 - 0.51) 2006 Modelled IHME
0.42 (0.33 - 0.51) 2005 Modelled IHME
0.42 (0.34 - 0.51) 2004 Modelled IHME
0.42 (0.34 - 0.51) 2003 Modelled IHME
0.42 (0.34 - 0.51) 2002 Modelled IHME
0.42 (0.34 - 0.52) 2001 Modelled IHME
0.42 (0.34 - 0.52) 2000 Modelled IHME
0.43 (0.34 - 0.52) 1999 Modelled IHME
0.43 (0.35 - 0.53) 1998 Modelled IHME
0.43 (0.35 - 0.53) 1997 Modelled IHME
0.44 (0.35 - 0.54) 1996 Modelled IHME
0.44 (0.35 - 0.54) 1995 Modelled IHME
0.44 (0.35 - 0.54) 1994 Modelled IHME
0.44 (0.35 - 0.54) 1993 Modelled IHME
0.44 (0.35 - 0.53) 1992 Modelled IHME
0.44 (0.35 - 0.54) 1991 Modelled IHME
0.43 (0.34 - 0.54) 1990 Modelled IHME
Showing out of
Show more

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
16 (11 - 22) 2019 Modelled IHME
16 (11 - 22) 2018 Modelled IHME
16 (11 - 22) 2017 Modelled IHME
16 (11 - 22) 2016 Modelled IHME
16 (11 - 21) 2015 Modelled IHME
16 (11 - 21) 2014 Modelled IHME
16 (11 - 22) 2013 Modelled IHME
16 (11 - 22) 2012 Modelled IHME
16 (11 - 22) 2011 Modelled IHME
16 (11 - 22) 2010 Modelled IHME
16 (11 - 22) 2009 Modelled IHME
16 (11 - 22) 2008 Modelled IHME
16 (11 - 22) 2007 Modelled IHME
16 (11 - 22) 2006 Modelled IHME
16 (11 - 22) 2005 Modelled IHME
17 (11 - 22) 2004 Modelled IHME
17 (12 - 23) 2003 Modelled IHME
17 (11 - 23) 2002 Modelled IHME
17 (11 - 23) 2001 Modelled IHME
17 (11 - 23) 2000 Modelled IHME
17 (12 - 23) 1999 Modelled IHME
17 (12 - 24) 1998 Modelled IHME
18 (12 - 24) 1997 Modelled IHME
18 (12 - 25) 1996 Modelled IHME
18 (12 - 25) 1995 Modelled IHME
18 (12 - 25) 1994 Modelled IHME
18 (12 - 25) 1993 Modelled IHME
18 (12 - 25) 1992 Modelled IHME
18 (12 - 25) 1991 Modelled IHME
18 (12 - 25) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
300 (0 - 0) 2016 Survey/reported Harm Reduction International, 2016

Percent of PWID accessing OST

People who inject drugs (PWID)
Download
Value (%) Year Type Source
0 2016 Survey/reported Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Overview

Prevalence (national)

Modelled

HBV (HBsAg+)
5.03 (%)
2019
(4.31 - 5.86(%))
IHME
HCV (RNA/cAg+)
0.43 (%)
2019
(0.34 - 0.52(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
20
2019
(16 - 25)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
9
2019
(6 - 11)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
2.08 (%)
2019, latest modelled
(1.41 - 2.84(%))
IHME

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
0
2016
(0 - 0)
Harm Reduction International, 2016
Eligible for HBV generic medicines
Eligible for HCV generic medicines